[HTML][HTML] Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of …

J Bae, E Han, HW Lee, CY Park… - Diabetes & …, 2024 - synapse.koreamed.org
Since the role of the liver in metabolic dysfunction, including type 2 diabetes mellitus, was
demonstrated, studies on non-alcoholic fatty liver disease (NAFLD) and metabolic …

Strategy for treating MAFLD: Electroacupuncture alleviates hepatic steatosis and fibrosis by enhancing AMPK mediated glycolipid metabolism and autophagy in T2DM …

H Duan, S Song, R Li, S Hu, S Zhuang, S Liu… - Diabetology & Metabolic …, 2024 - Springer
Background Recent studies have highlighted type 2 diabetes (T2DM) as a significant risk
factor for the development of metabolic dysfunction-associated fatty liver disease (MAFLD) …

γ-Glutamylcysteine restores glucolipotoxicity-induced islet β-cell apoptosis and dysfunction via inhibiting endoplasmic reticulum stress

J Zhou, Y Shi, L Zhao, R Wang, L Luo, Z Yin - Toxicology and Applied …, 2025 - Elsevier
Purpose The impaired function of islet β-cell is associated with the pathogenesis of type 2
diabetes mellitus (T2DM). γ-glutamylcysteine (γ-GC), an immediate precursor of glutathione …

Strategy for treating MAFLD: Electroacupuncture alleviates hepatic steatosis and fibrosis by enhancing AMPK mediated glycolipid metabolism and autophagy in T2DM …

D Haoru, S Song, R Li, S Hu, S Zhuang, X Li, W Gao - 2024 - researchsquare.com
Background: Recent studies havehighlighted type 2 diabetes (T2DM) as a significant risk
factor for the development of metabolic dysfunction-associated fatty liver disease (MAFLD) …